Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03058003 |
Other study ID # |
CI-IRB-20170124001 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 2016 |
Est. completion date |
April 2021 |
Study information
Verified date |
August 2021 |
Source |
Caps Research Network |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
To investigate the use of balance as a screening tool for Central Sensitization, a condition
of the nervous system that is associated with the development and maintenance of chronic
pain. This is done by comparing the scores of a gold standard screening tool (the Central
Sensitization Inventory) with balance data.
Description:
First, subjects will be asked to answer a brief medical questionnaire pertaining their
general health status: since some of the subjects will be self-assessed to be "healthy" (no
medical examination will be conducted to determine if this is indeed the case), the
questionnaire will be used to determine if there are any possible known causes of poor
balance performance. The questionnaire will not constitute an inclusion/exclusion criterion,
it just has a classification purpose.
Subjects will then be asked to fill in the Central Sensitization Inventory (CSI), scoring
each of the 25 items on a scale from 0 (never) to 4 (always).
Then, subjects will stand for 2 minutes on a compliant surface (a 4" tall foam cushion of
known mechanical properties) to "learn" how to stand on it. Afterward, they will undergo
posturography testing using the extended modified Clinical Testing of Sensory Integration in
Balance (ext_mCTSIB) protocol: the subjects will be required to stand on a hard or compliant
surface in a comfortable posture, feet shoulder width, with eyes open or closed, arms to the
side and free to move, gazing forward, and breathing normally, with head straight, turned
right or left, flexed or extended.